HIV/AIDS
The General Public Supports Breaking Drug Patents To Ensure Access To HIV/AIDS Drugs In Poorer Countries
Published in AIDS Weekly, July 9th, 2007
In May 2007, Brazil's President Luiz Inacio Lula da Silva took steps to make an inexpensive generic version of a patented AIDS drug manufactured by Merck & Co. by issuing a compulsory license that would bypass Merck's patent. A compulsory license is a legal mechanism that allows a country to manufacture or buy generic versions of patented drugs while paying the patent holder only a small royalty. Most adults in the U.S. (57%) say they are in favor of the country's decision, while 20 percent say they are opposed.
Overall, sixty-one percent of U.S. adults believe poorer countries should be allowed to break companies' patents on HIV/AIDS drugs if doing so would help them...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of AIDS Weekly
Source: AIDS Weekly (2007-07-09)
More Articles from AIDS Weekly
- HIV/AIDS
HIV care can be successfully delivered to Thai prisoners - HIV/AIDS
Needle-stick injuries are common but unreported by surgeons in training - HIV/AIDS Co-Infection
New Vaccine Prevents CMV Infection and Disease in Mice - DNA Vaccines
Althea Technologies Contracted by GeoVax to Produce a Phase 2 AIDS Vaccine - HIV/AIDS
Abbott and Abbott Fund Expand Commitment to Improving Health Care in Tanzania With Dedication of New Lab and Launch of New Diagnostic Programs - HIV/AIDS
Abstinence-Only Earmark Removed - More from this issue of AIDS Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
